Form 8-K - Current report:
SEC Accession No. 0001079973-26-000068
Filing Date
2026-01-12
Accepted
2026-01-12 08:00:43
Documents
14
Period of Report
2026-01-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K toi_8k.htm   iXBRL 8-K 29708
2 EXHIBIT 99.1 ex99x1.htm EX-99.1 14653
  Complete submission text file 0001079973-26-000068.txt   262078

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE toi-20260112.xsd EX-101.SCH 3911
4 XBRL DEFINITION FILE toi-20260112_def.xml EX-101.DEF 26803
5 XBRL LABEL FILE toi-20260112_lab.xml EX-101.LAB 37032
6 XBRL PRESENTATION FILE toi-20260112_pre.xml EX-101.PRE 25427
16 EXTRACTED XBRL INSTANCE DOCUMENT toi_8k_htm.xml XML 5588
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

EIN.: 843562323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39248 | Film No.: 26524731
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)